News Focus
News Focus
icon url

DewDiligence

02/17/11 4:57 PM

#115009 RE: jbog #115008

EXEL—Of 62 patients evaluable by bone scan, 53 (85%) achieved either complete or partial resolution of metastatic lesions on bone scan by independent radiologist review.

Was the CR-vs-PR breakdown disclosed?
icon url

BTH

02/17/11 5:01 PM

#115010 RE: jbog #115008

This all sounds very good...

However, this is Exelixis the company of hype and under-delivery, so can someone make a breakdown of this?
icon url

dumaflotchie

02/17/11 7:44 PM

#115026 RE: jbog #115008

Prostate-specific antigen (PSA) changes were observed to be independent of reduction or stability of tumor target lesions, resolution of bone lesions on bone scan, and changes in bone pain.

What do you make of the lack of PSA coorelation? This lack of coorelation has been demonstrated in other studies early on but the PSA has been used by so many to track recurrence of this disease. Maybe too early in followup to identify trend?

Practically everything else points to response from anemia improvement to reduction in alk phos to bone scan improvments.......but not PSA.

Is this an anomoly or commonly seen?